Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
Irobest tablet is the preparation of iron, folic acid and zinc. In this preparation, iron is
present as iron (III) hydroxide polymaltose complex, a noble iron preparation. It contains
non-ionic ferric iron and polymaltose in a stable complex. This complex facilitates a
controlled absorption of the iron when it comes in contact with the mucosal cell surface.
Due to non-ionic nature, iron (III) hydroxide polymaltose complex is more stable than
conventional iron form. Folic acid helps in the proper development of the fetus. Zinc
keeps enzymes working and helps to metabolize proteins.